Cargando…

Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma.

COVID-19 convalescent plasma (CCP) could improve the clinical outcome of COVID-19 patients when high-titer CCP is administered in early stages of disease. However, CCP donors have a risk profile like first-time donors, pathogen reduction treatment (PRT) may mitigate such risk but should not impact C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hindawi, Salwa, Elgemmezi, Tarek, A. El-Kafrawy, Sherif, Samadani, Hani, Tilmisani, Mayasim, Assiri, Omar, Raml, Mohammad, I. Azhar, Esam, Badawi, Maha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984302/ https://www.ncbi.nlm.nih.gov/pubmed/36922242 http://dx.doi.org/10.1016/j.transci.2023.103688

Ejemplares similares

Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors
por: Almalki, Saud, et al.
Publicado: (2021)

Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia
por: Alandijany, Thamir A., et al.
Publicado: (2021)

Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma
por: Azhar, Esam I., et al.
Publicado: (2020)

Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
por: Tolah, Ahmed Majdi K., et al.
Publicado: (2021)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells
por: Sartaj Sohrab, Sayed, et al.
Publicado: (2022)

Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells
por: Sohrab, Sayed Sartaj, et al.
Publicado: (2022)

Lack of Evidence on Association between Iron Deficiency and COVID-19 Vaccine-Induced Neutralizing Humoral Immunity
por: Faizo, Arwa A., et al.
Publicado: (2023)

Tackling dengue fever: Current status and challenges
por: Nedjadi, Taoufik, et al.
Publicado: (2015)

IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
por: Abbas, Aymn Talat, et al.
Publicado: (2018)

Neutralizing antibodies in convalescent patients
por: Uhl, Lion F. K., et al.
Publicado: (2020)

The use of transfusion quality indicators as a tool for hemovigilance system implementation at a tertiary care center in Saudi Arabia
por: Hindawi, Salwa I., et al.
Publicado: (2016)

Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency
por: Focosi, D., et al.
Publicado: (2021)

Computational Design and Experimental Evaluation of MERS-CoV siRNAs in Selected Cell Lines
por: Sohrab, Sayed S., et al.
Publicado: (2023)

Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology
por: Yonemura, Susan, et al.
Publicado: (2021)

In silico prediction and experimental validation of siRNAs targeting ORF1ab of MERS-CoV in Vero cell line
por: Sohrab, Sayed Sartaj, et al.
Publicado: (2021)

Designing and evaluation of MERS-CoV siRNAs in HEK-293 cell line
por: Sohrab, Sayed Sartaj, et al.
Publicado: (2021)

In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells
por: El-Kafrawy, Sherif Aly, et al.
Publicado: (2021)

Delivery of siRNAs against MERS-CoV in Vero and HEK-293 cells: A comparative evaluation of transfection reagents
por: Sartaj Sohrab, Sayed, et al.
Publicado: (2023)

IgY antibodies: The promising potential to overcome antibiotic resistance
por: El-Kafrawy, Sherif A., et al.
Publicado: (2023)

Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia
por: Yasir, Muhammad, et al.
Publicado: (2023)

Computational and In Vitro Experimental Investigations Reveal Anti-Viral Activity of Licorice and Glycyrrhizin against Severe Acute Respiratory Syndrome Coronavirus 2
por: Tolah, Ahmed M., et al.
Publicado: (2021)

Rapid and Reliable Detection of SARS-CoV-2 Using Direct RT-LAMP
por: El-Kafrawy, Sherif A., et al.
Publicado: (2022)

Molecular Detection of Influenza A and B Viruses in Four Consecutive Influenza Seasons 2015–16 to 2018–19 in a Tertiary Center in Western Saudi Arabia
por: Althaqafi, Abdulhakeem, et al.
Publicado: (2021)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Middle East respiratory syndrome coronavirus—a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins
por: Azhar, Esam I., et al.
Publicado: (2023)

Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection
por: El-Kafrawy, Sherif A., et al.
Publicado: (2021)

Seroprevalence of Toscana and sandfly fever Sicilian viruses in humans and livestock animals from western Saudi Arabia
por: Al-numaani, Sarah Ayman, et al.
Publicado: (2023)

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
por: Dulipsingh, Latha, et al.
Publicado: (2023)

A Direct Method for RT-PCR Detection of SARS-CoV-2 in Clinical Samples
por: El-Kafrawy, Sherif A., et al.
Publicado: (2021)

Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model
por: Abbas, Aymn T., et al.
Publicado: (2020)

A Reliable Indirect ELISA Protocol for Detection of Human Antibodies Directed to SARS-CoV-2 NP Protein
por: Faizo, Arwa A., et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

Discovery of Bispecific Lead Compounds from Azadirachta indica against ZIKA NS2B-NS3 Protease and NS5 RNA Dependent RNA Polymerase Using Molecular Simulations
por: Kumar, Sanjay, et al.
Publicado: (2022)

Discovery of Small Molecules from Echinacea angustifolia Targeting RNA-Dependent RNA Polymerase of Japanese Encephalitis Virus
por: Yadav, Pardeep, et al.
Publicado: (2022)

In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea
por: Bajrai, Leena Hussein, et al.
Publicado: (2022)

Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia
por: Ahmed, Waleed A., et al.
Publicado: (2021)

Evaluation of Extraction Methods for Clinical Metagenomic Assay
por: Farraj, Suha A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9qvmu87roqjb1eruqduq0o7k2b